China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

Sinopharm Foreign Trade (Beijing) Co., Ltd., subsidiary of China National Pharmaceutical Group Corporation signed the agency agreement for the “Immunocytochemical Detection Kit of p16/Ki-67” (hereinafter referred to as "p16/Ki-67”) with MXB Biotechnologies Co., Ltd., subsidiary of BSBE.

Consumer genetics testing and medical diagnostics pioneer DnaNudge today announces that it has signed a new major distributor agreement that will speed the commercial roll-out of its breakthrough rapid genetic testing solutions across Spain.

The proposed acquisition comes shortly after a court ordered Hill-Rom to complete its acquisition of Bardy Diagnostics, a cardiac monitoring specialist, for $375 million.

According to "Medical Device and Diagnostics Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type and Services and Geography", the market is expected to reach US$ 20,336.08 million in 2028 from US$ 12,314.65 million in 2021.

QIAGEN to join the DAX on September 20, 2021, the effective date for changes in index composition. QIAGEN to remain in TecDAX comprised of the 30 largest German technology sector companies.

Mindray has purchased 3,048,662 shares through the stock repurchase special securities account, accounting for 0.2508% of the total share capital of the company. The total amount paid is almost 1 Billon CNY.

China has announced plans to set up a third stock exchange to serve small and medium-sized businesses.

Digital health technology firm Cue Health is seeking up to $100 million in a proposed initial public offering, it said in a registration statement filed on Wednesday with the US Securities and Exchange Commission.

Belgian molecular diagnostics maker Biocartis on Thursday reported a 31 percent year-over-year increase in revenues for the first half of 2021 on strong sales of its Idylla system and related test cartridges.

August 20, the Hurun Research Institute in association with Jiaxing City released the 2021 Hurun Global 500.